Summary
C5b-9(m) is a specific and sensitive marker for myocardial cell necrosis. The diagnostic value of this marker would be considerably limited in forensic practice if its immuno-histochemical demonstration were hampered by putrefaction or autolysis. We could demonstrate C5b-9(m) immunohistochemically in necrotic myocardium due to infarction up to the 11th day of experimentally induced putrefaction and autolysis, when reliable demonstration of myocardial infarction with hematoxylin-eosin was no longer possible. Under the experimental conditions of this study, no false positive immunohistochemical staining occurred.
Zusammenfassung
C5b-9(m) ist ein spezifischer und sensitiver Marker für Myokardzellnekrosen. Sein diagnostischer Wert in der forensischen Praxis wäre aber stark eingeschränkt, wenn die immunhistologische Darstellung des Komplexes empfindlich gegen Autolyse und Fäulnis wäre. Wir konnten auch nach elftägiger experimentell forcierter Autolyse und Fäulnis C5b-9(m) immunhistochemisch in infarziertem Myokard sicher nachweisen. Zu diesem Zeitpunkt wäre die Diagnose eines Myokardinfarktes in der Hämatoxylin-Eosin-Färbung nicht mehr möglich gewesen. Im Untersuchungszeitraum waren falsch positive immunhistologische Färbungen nicht zu beobachten.
Similar content being viewed by others
References
Sahai VB, Knight B (1976) The post-mortem detection of early myocardial infarction by a simple fluorescent method. Med Sci Law 16:17–20
Knight B (1976) Investigation of sudden death from myocardial ischaemia. Forensic Sci 8:33–36
Lie JT, Holley KE, Kampa WR, Titus JL (1971) New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Mayo Clin Proc 46:319–327
Rajs J, Jakobsson S (1976) Experiences with the haematoxylin basic fuchsin picric acid stain method for morphological diagnosis of myocardial ischaemia - an experimental study in forensic pathology. Forensic Sci 8:37–48
Zollinger U (1983) Die Chromotrop-Anilinblau-Färbung zur besseren Darstellung frische Herzmuskelfaserschädigungen. Z Rechtsmed 90:269–275
Fechner GGP, Sivaloganathan S (1987) Demonstration of myocardial infarction in putrefying bodies. J Clin Pathol 40:922–924
Schaefer H, Mathey D, Hugo F, Bhakdi S (1986) Deposition of the terminal C5b-9 complex in infarcted areas of human myocardium. J Immunol 137:1945–1949
Rus HG, Niculescu F, Vlaicu R (1987) Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis. Immunol Lett 16:15–20
Brinkmann B, Sepulchre MA, Fechner G (1993) The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage. Int J Leg Med 106:135–141
Thomsen H, Schulz A, Bhakdi S (1990) Immunohistochemical detection of C5b-9 complement complex in early stages of myocardic necrosis in paraffin sections. Z Rechtsmed 103:199–206
Bhakdi S, Tranum-Jensen J (1987) Damage to mammalian cells by proteins that form transmembrane pores. Rev Physiol Biochem Pharmacol 107:147–223
Vlaicu R, Niculescu F, Rus HG, Cristea A (1985) Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 57:163–177
Seifert PS, Hugo F, Tranum-Jensen J, Zahringer U, Muhly M, Bhakdi S (1990) Isolation and characterization of a complement-activating lipid extracted from atherosclerotic lesions. J Exp Med 172:547–557
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomsen, H., Held, H. Susceptibility of C5b-9(m) to postmortem changes. Int J Leg Med 106, 291–293 (1994). https://doi.org/10.1007/BF01224773
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01224773